Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion

The Journal of Clinical Endocrinology and Metabolism
Fernanda S NovaesBruno Geloneze

Abstract

Bariatric surgery often results in remission of the diabetic state in obese patients. Increased incretin effect seems to play an important role in the glycemic improvements after Roux-en-Y gastric bypass, but the impact of biliopancreatic diversion (BPD) remains unexplored. The objective was to elucidate the effect of BPD on the incretin effect and its interplay with beta-cell function and insulin sensitivity (IS) in obese subjects with type 2 diabetes (T2DM). Twenty-three women were studied: a control group of 13 lean, normal glucose-tolerant women (lean NGT) studied once and 10 obese patients with T2DM studied before, 1 and 12 months after BPD. The ObeseT2DM group underwent BPD. The main outcome measure was the change in incretin effect as measured by the isoglycemic intravenous glucose infusion test. Secondary outcomes encompassed IS and beta-cell function. At baseline, the incretin effect was lower in obese T2DM compared to lean NGT (P < .05). One month after BPD, the incretin effect was not changed, but at 12 months it reached the level of the lean NGT group (P > .05). IS improved (P < .05) 1 month after BPD and at 12 months it resembled the levels of the lean NGT group. Insulin secretory rate and beta-cell glucose sensiti...Continue Reading

References

Jan 1, 1986·Diabetologia·M NauckW Creutzfeldt
Jun 1, 2005·Archives of Medical Research·Jack L Leahy
Jun 29, 2006·Diabetes·Caterina GuidoneGeltrude Mingrone
Apr 24, 2008·The Journal of Clinical Endocrinology and Metabolism·Blandine LaferrèreBlanca Olivan
Oct 18, 2008·Diabetes, Obesity & Metabolism·A Mari, E Ferrannini
Mar 11, 2009·The American Journal of Medicine·Henry BuchwaldIsabella Sledge
Feb 16, 2010·Diabetes & Metabolism·G Mingrone, L Castagneto-Gissey
Sep 29, 2011·Metabolism: Clinical and Experimental·Andrea TuraAndrea Mari
Oct 21, 2011·Arquivos brasileiros de endocrinologia e metabologia·J B DixonUNKNOWN International Diabetes Federation Taskforce on Epidemiology and Prevention
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Aug 11, 2015·IEEE Journal of Biomedical and Health Informatics·Karam ChoiSungwan Kim
Oct 21, 2016·Obesity Surgery·Ana Carolina Junqueira VasquesBruno Geloneze

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.